TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH July 23, 1999
TCL Archive Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH. January 21, 2000
TCL Archive Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach February 7, 2014